Deutsche Bank has published a research report on Medtronic MDT, maintaining their current position.
In the report, Deutsche Bank wrote, "We are not disillusioned, nor do we think the new CEO is, about the enormity of the task ahead. MDT has struggled for a decade; given its sheer size it will take time to turn around. However, unlike some undergoing turnarounds (e.g. Boston Scientific), we believe Medtronic has a better existing foundation."
Deutsche Bank rated Medtronic a BUY with a price target of $43.00. Medtronic closed Tuesday at $33.10.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in